193 related articles for article (PubMed ID: 23251343)
1. Novel diabetic mouse models as tools for investigating diabetic retinopathy.
Kador PF; Zhang P; Makita J; Zhang Z; Guo C; Randazzo J; Kawada H; Haider N; Blessing K
PLoS One; 2012; 7(12):e49422. PubMed ID: 23251343
[TBL] [Abstract][Full Text] [Related]
2. Novel transgenic mouse models develop retinal changes associated with early diabetic retinopathy similar to those observed in rats with diabetes mellitus.
Guo C; Zhang Z; Zhang P; Makita J; Kawada H; Blessing K; Kador PF
Exp Eye Res; 2014 Feb; 119():77-87. PubMed ID: 24370601
[TBL] [Abstract][Full Text] [Related]
3. Loss-of-function mutation of serine racemase attenuates retinal ganglion cell loss in diabetic mice.
Jiang H; Du J; Song J; Li Y; Wu M; Zhou J; Wu S
Exp Eye Res; 2018 Oct; 175():90-97. PubMed ID: 29913163
[TBL] [Abstract][Full Text] [Related]
4. The Ins2Akita mouse as a model of early retinal complications in diabetes.
Barber AJ; Antonetti DA; Kern TS; Reiter CE; Soans RS; Krady JK; Levison SW; Gardner TW; Bronson SK
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2210-8. PubMed ID: 15914643
[TBL] [Abstract][Full Text] [Related]
5. Long-term lutein administration attenuates retinal inflammation and functional deficits in early diabetic retinopathy using the Ins2
Wang W; Tam KC; Ng TC; Goit RK; Chan KLS; Lo ACY
BMJ Open Diabetes Res Care; 2020 Jul; 8(1):. PubMed ID: 32665315
[TBL] [Abstract][Full Text] [Related]
6. Decreased lysyl oxidase level protects against development of retinal vascular lesions in diabetic retinopathy.
Kim D; Mecham RP; Nguyen NH; Roy S
Exp Eye Res; 2019 Jul; 184():221-226. PubMed ID: 31022398
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of trophic factors contributes to diabetic retinopathy in the Ins2
Araújo RS; Silva MS; Santos DF; Silva GA
Exp Eye Res; 2020 May; 194():108027. PubMed ID: 32259534
[TBL] [Abstract][Full Text] [Related]
8. BTBR ob/ob mouse model of type 2 diabetes exhibits early loss of retinal function and retinal inflammation followed by late vascular changes.
Lee VK; Hosking BM; Holeniewska J; Kubala EC; Lundh von Leithner P; Gardner PJ; Foxton RH; Shima DT
Diabetologia; 2018 Nov; 61(11):2422-2432. PubMed ID: 30094465
[TBL] [Abstract][Full Text] [Related]
9. Reduction of Glut1 in the Neural Retina But Not the RPE Alleviates Polyol Accumulation and Normalizes Early Characteristics of Diabetic Retinopathy.
Holoman NC; Aiello JJ; Trobenter TD; Tarchick MJ; Kozlowski MR; Makowski ER; De Vivo DC; Singh C; Sears JE; Samuels IS
J Neurosci; 2021 Apr; 41(14):3275-3299. PubMed ID: 33622781
[TBL] [Abstract][Full Text] [Related]
10. An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia.
Frank RN; Amin R; Kennedy A; Hohman TC
Arch Ophthalmol; 1997 Aug; 115(8):1036-47. PubMed ID: 9258227
[TBL] [Abstract][Full Text] [Related]
11. Antagonising Wnt/β-catenin signalling ameliorates lens-capsulotomy-induced retinal degeneration in a mouse model of diabetes.
Hombrebueno JR; Ali IHA; Ma JX; Chen M; Xu H
Diabetologia; 2018 Nov; 61(11):2433-2446. PubMed ID: 30019207
[TBL] [Abstract][Full Text] [Related]
12. Reduced ocular blood flow as an early indicator of diabetic retinopathy in a mouse model of diabetes.
Muir ER; Rentería RC; Duong TQ
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6488-94. PubMed ID: 22915034
[TBL] [Abstract][Full Text] [Related]
13. The effects of age and Cx3cr1 deficiency on retinal microglia in the Ins2(Akita) diabetic mouse.
Kezic JM; Chen X; Rakoczy EP; McMenamin PG
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):854-63. PubMed ID: 23307960
[TBL] [Abstract][Full Text] [Related]
14. Early diabetes-induced biochemical changes in the retina: comparison of rat and mouse models.
Obrosova IG; Drel VR; Kumagai AK; Szábo C; Pacher P; Stevens MJ
Diabetologia; 2006 Oct; 49(10):2525-33. PubMed ID: 16896942
[TBL] [Abstract][Full Text] [Related]
15. Acute onset of diabetic pathological changes in transgenic mice with human aldose reductase cDNA.
Yamaoka T; Nishimura C; Yamashita K; Itakura M; Yamada T; Fujimoto J; Kokai Y
Diabetologia; 1995 Mar; 38(3):255-61. PubMed ID: 7758869
[TBL] [Abstract][Full Text] [Related]
16. A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy.
Sun W; Oates PJ; Coutcher JB; Gerhardinger C; Lorenzi M
Diabetes; 2006 Oct; 55(10):2757-62. PubMed ID: 17003340
[TBL] [Abstract][Full Text] [Related]
17. Loss of X-box binding protein 1 in Müller cells augments retinal inflammation in a mouse model of diabetes.
Yang J; Chen C; McLaughlin T; Wang Y; Le YZ; Wang JJ; Zhang SX
Diabetologia; 2019 Mar; 62(3):531-543. PubMed ID: 30612139
[TBL] [Abstract][Full Text] [Related]
18. The effect of total lignans from Fructus Arctii on Streptozotocin-induced diabetic retinopathy in Wistar rats.
Zhang H; Gao Y; Zhang J; Wang K; Jin T; Wang H; Ruan K; Wu F; Xu Z
J Ethnopharmacol; 2020 Jun; 255():112773. PubMed ID: 32199990
[TBL] [Abstract][Full Text] [Related]
19. Absence of clinical correlates of diabetic retinopathy in the Ins2Akita retina.
McLenachan S; Chen X; McMenamin PG; Rakoczy EP
Clin Exp Ophthalmol; 2013 Aug; 41(6):582-92. PubMed ID: 23433122
[TBL] [Abstract][Full Text] [Related]
20. Retinal blood flow abnormalities following six months of hyperglycemia in the Ins2(Akita) mouse.
Wright WS; Yadav AS; McElhatten RM; Harris NR
Exp Eye Res; 2012 May; 98(1):9-15. PubMed ID: 22440813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
